Ferticility care awards
Contact
EN
  • HR
  • IT
  • Contact
  • ASSISTED REPRODUCTION

    ABOUT ASSISTED REPRODUCTION

    • Assisted reproduction
    • Diagnosis and treatment of infertility
    • Preparation for AR
    • FAQ
    • Legal regulations
    • Glossary of terms

    INFERTILITY

    • Infertility in women
    • Infertility in men
    • Spermiogram
    • Prevention of OHSS
    • Combination protocols
    • PCOS

    METHODS OF ASSISTED REPRODUCTION

    • Cycle management
    • Stimulation protocols
    • IUI insemination
    • IVF/ICSI
    • CryoET

    LABORATORY PROCEDURES

    • IVF/ICSI
    • PICSI
    • Sperm DNA fragmentation
    • Determination of oxidative stress in ejaculate
    • Cryopreservation of semen
    • Vitrification of embryos and oocytes
    • Social freezing for cancer patients
    • Freeze all technology
    • TESE, TESA, PESA
    • EmbryoGlue
  • GYNECOLOGY AND OBSTETRICS

    GYNECOLOGY AND OBSTETRICS

    • Gynecology and pregnancy
    • Advanced ultrasound diagnostics
    • Gynecological endocrinology and PCOS
    • Pathology of the uterus
    • Endometriosis
    • Menopause
    • Gynecology for young people
    • Family planning and contraception
  • HYSTEROSCOPY

    HYSTEROSCOPY

    • Outpatient hysteroscopy
    • Outpatient hysteroscopy - instructions for patients
  • MIA polyclinic

    MIA polyclinic

    • Contacts and working hours
    • MIA polyclinic
    • PRONATAL and MIA polyclinic
    • Media contact
    • Expert Council
IVF/ICSI

IVF/ICSI

IVF/ICSI

IVF (In vitro fertilization) and ICSI (Intracytoplasmic Sperm Injection)

During the classic IVF procedure (In Vitro Fertilization) in laboratory conditions, we allow the best sperm to fertilize the egg. 50,000 processed sperm are added to each oocyte. That is, if the semen after processing contains a sufficient number of regular and motile sperm, their insemination is carried out in the wells with egg cells and the sperm are allowed to fertilize the egg spontaneously. Under optimal conditions, fertilisation can be confirmed as early as 16 to 20 hours after insemination of the sperm (success rate 65-85%).

ICSI, or microinjection of sperm into the cytoplasm of an egg cell, is a microsurgical procedure that allows fertilization of an oocyte that would not occur with standard IVF technology. It is primarily a method in the treatment of male infertility. Individual sperm insertion bypasses some well-known barriers to fertilization (with some additional advantages):

  • abnormalities: zona pellucida
  • defective sperm count and kinetics
  • presence of antibodies to sperms
  • teratozoospermia
  • dysfunction of the sperm acrosome prevents polyspermic fertilization

  This method requires the knowledge and experience of an embryologist, and fertilization control is performed after 16-20 hours and has a 70-85% success rate. ICSI is a complex microsurgical procedure that takes an average of 5 to 10 minutes per oocyte. 

What determines IVF success?

 In the early stages, 35-40 years ago, the success rate of IVF was less than 5%. Today, the success rate of the IVF/ICSI method in young patients is between 40% and 60% per fresh attempt. The success rate is the same after freezing and vitrification of embryos and even oocytes.

How the results are presented is essential for evaluating success. According to ET (embryo transfer), they are 12 to 15% higher than the presentation according to the IVF cycle started, so the failure rate must be taken into account during the procedure.

The dropout rate for younger women is between 2 and 5%, while for women over 41 years of age, the rate is between 30 and 50%. Patients with poor response (poor ovarian response - POR) have more discontinuations, approximately 20-30% of cycles. Patients with fewer than 4 oocytes in the procedure (POR) have a significantly lower success rate - approximately an LBR of 10-12%.

Temporary abandonment of ET is now more common in patients with an exaggerated response to stimulation (PCOS patients), where all embryos are frozen due to the risk of hyperstimulation (freeze all technology), so there is no fresh ET. IVF outcomes are also affected by the incidence of spontaneous abortion, which is low in young people (8-10%) and high in patients over 40 (20-40%).

Preparation for AR

Member of the PRONATAL Group

The PRONATAL Group with its 11 centers is a European leader in the field of reproductive medicine and assisted reproduction.

Contact

  • Group 3 Zametska 13, Rijeka
  • Group 4 +385 51 309 950
  • Group 3 info@miapoliklinika.hr

Opening hours

  • Group 5 Monday - Thursday  8.00 - 20.00
      Friday  8.00 - 16.00
      Saturday 8.00 - 13.00

Important links

  • Infertility treatment
  • Artificial insemination
  • Glosary of terms
  • Certificates and annual reports
  • Information for patients
  • Contact
  • Price list
  • MIA
Write to us
Copyright © 2025 PRONATAL. Member of MEDICON Group | Cookies settings
Made by Brandmark Boutique & Apploud Digital